Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to -$11.0 million.

  • Chemours' Change in Receivables fell 12244.9% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.0 million, marking a year-over-year decrease of 12463.77%. This contributed to the annual value of $139.0 million for FY2024, which is 89285.71% up from last year.
  • Latest data reveals that Chemours reported Change in Receivables of -$11.0 million as of Q3 2025, which was down 12244.9% from $63.0 million recorded in Q2 2025.
  • Chemours' 5-year Change in Receivables high stood at $294.0 million for Q1 2022, and its period low was -$347.0 million during Q4 2022.
  • Over the past 5 years, Chemours' median Change in Receivables value was $55.0 million (recorded in 2021), while the average stood at $23.7 million.
  • As far as peak fluctuations go, Chemours' Change in Receivables soared by 183636.36% in 2021, and later plummeted by 25090.91% in 2022.
  • Quarter analysis of 5 years shows Chemours' Change in Receivables stood at -$118.0 million in 2021, then crashed by 194.07% to -$347.0 million in 2022, then surged by 42.94% to -$198.0 million in 2023, then increased by 0.51% to -$197.0 million in 2024, then soared by 94.42% to -$11.0 million in 2025.
  • Its Change in Receivables was -$11.0 million in Q3 2025, compared to $63.0 million in Q2 2025 and $111.0 million in Q1 2025.